Oncotelic Therapeutics, Inc. Interest Expense
Oncotelic Therapeutics, Inc. (OTLC) reported Interest Expense of $234.71 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-15
- Oncotelic Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $234.71K, a 40.47% decline year-over-year.
- Oncotelic Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $207.69K, a 78.63% decline year-over-year.
- Oncotelic Therapeutics, Inc. interest expense for the quarter ending 2023-09-30 was $185.42K, a 69.44% decline year-over-year.
- Oncotelic Therapeutics, Inc. interest expense for the quarter ending 2023-06-30 was $257.40K, a 76.49% decline year-over-year.
- Oncotelic Therapeutics, Inc. interest expense for fiscal 2023 was $1.04M, a 64.83% decline from fiscal 2022.
- Oncotelic Therapeutics, Inc. interest expense for fiscal 2022 was $2.97M, a 48.34% increase from fiscal 2021.
- Oncotelic Therapeutics, Inc. interest expense for fiscal 2021 was $2.00M, a 0.22% increase from fiscal 2020.
- Oncotelic Therapeutics, Inc. interest expense for fiscal 2020 was $2.00M, a 166.63% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $234.71K 10-Q · filed 2024-05-15 | $442.39K derived: sum of 2 quarters · filed 2024-05-15 | $627.82K derived: sum of 3 quarters · filed 2024-05-15 | $885.22K derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-12-31 | $207.69K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $393.11K derived: sum of 2 quarters · filed 2024-04-12 | $650.51K derived: sum of 3 quarters · filed 2024-04-12 | $1.04M 10-K · filed 2024-04-12 | ||||
| 2023-09-30 | $185.42K 10-Q · filed 2023-11-14 | $442.82K derived: sum of 2 quarters · filed 2023-11-14 | $837.10K 10-Q · filed 2023-11-14 | $1.81M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-06-30 | $257.40K 10-Q · filed 2023-08-18 | $651.67K 10-Q · filed 2023-08-18 | $1.62M derived: sum of 3 quarters · filed 2024-05-15 | $2.23M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2023-03-31 | $394.28K 10-Q · filed 2024-05-15 | $1.37M derived: sum of 2 quarters · filed 2024-05-15 | $1.97M derived: sum of 3 quarters · filed 2024-05-15 | $3.07M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $971.88K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-12 | $1.58M derived: sum of 2 quarters · filed 2024-04-12 | $2.67M derived: sum of 3 quarters · filed 2024-04-12 | $2.97M 10-K · filed 2024-04-12 | ||||
| 2022-09-30 | $606.82K 10-Q · filed 2023-11-14 | $1.70M derived: sum of 2 quarters · filed 2023-11-14 | $2.00M 10-Q · filed 2023-11-14 | $2.60M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $1.09M 10-Q · filed 2023-08-18 | $1.39M 10-Q · filed 2023-08-18 | $1.99M derived: sum of 3 quarters · filed 2023-08-18 | $2.44M derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $297.46K 10-Q · filed 2023-05-22 | $900.03K derived: sum of 2 quarters · filed 2023-05-22 | $1.35M derived: sum of 3 quarters · filed 2023-05-22 | $1.78M derived: sum of 4 quarters · filed 2023-05-22 | ||||
| 2021-12-31 | $602.56K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-20 | $1.05M derived: sum of 2 quarters · filed 2023-04-20 | $1.48M derived: sum of 3 quarters · filed 2023-04-20 | $2.00M 10-K/A · filed 2023-04-20 | ||||
| 2021-09-30 | $445.36K 10-Q · filed 2022-11-18 | $879.34K derived: sum of 2 quarters · filed 2022-11-18 | $1.40M 10-Q · filed 2022-11-18 | $1.78M derived: sum of 4 quarters · filed 2022-11-18 | ||||
| 2021-06-30 | $433.98K 10-Q · filed 2022-08-22 | $954.89K 10-Q · filed 2022-08-22 | $1.34M derived: sum of 3 quarters · filed 2022-08-22 | $1.67M derived: sum of 4 quarters · filed 2022-08-22 | ||||
| 2021-03-31 | $520.91K 10-Q · filed 2022-05-23 | $520.91K 10-Q · filed 2021-05-24 | $904.00K derived: sum of 2 quarters · filed 2022-05-23 | $1.24M derived: sum of 3 quarters · filed 2022-05-23 | $1.37M derived: sum of 4 quarters · filed 2022-05-23 | |||
| 2020-12-31 | $383.09K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $714.55K derived: sum of 2 quarters · filed 2022-04-15 | $851.64K derived: sum of 3 quarters · filed 2022-04-15 | $2.00M 10-K · filed 2022-04-15 | ||||
| 2020-09-30 | $331.46K 10-Q · filed 2021-11-22 | $468.55K derived: sum of 2 quarters · filed 2021-11-22 | $1.62M 10-Q · filed 2021-11-22 | $2.28M derived: sum of 4 quarters · filed 2021-11-22 | ||||
| 2020-06-30 | $137.09K 10-Q · filed 2021-08-20 | $1.28M 10-Q · filed 2021-08-20 | $1.95M derived: sum of 3 quarters · filed 2021-08-20 | $2.01M derived: sum of 4 quarters · filed 2021-08-20 | ||||
| 2020-03-31 | $1.15M 10-Q · filed 2021-05-24 | $1.15M 10-Q · filed 2020-06-29 | $1.81M derived: sum of 2 quarters · filed 2021-05-24 | $1.87M derived: sum of 3 quarters · filed 2021-05-24 | $1.90M derived: sum of 4 quarters · filed 2021-05-24 | |||
| 2019-12-31 | $660.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $721.37K derived: sum of 2 quarters · filed 2021-04-15 | $749.48K derived: sum of 3 quarters · filed 2021-04-15 | $749.48K 10-K · filed 2021-04-15 | $749.60K 10-K · filed 2020-05-14 | |||
| 2019-09-30 | $60.41K 10-Q · filed 2020-11-16 | $88.52K derived: sum of 2 quarters · filed 2020-11-16 | $88.52K 10-Q · filed 2020-11-16 | $88.64K 10-Q · filed 2019-11-19 | ||||
| 2019-06-30 | $28.11K 10-Q · filed 2020-08-14 | $28.23K 10-Q · filed 2019-08-19 | $28.11K 10-Q · filed 2020-08-14 | $28.23K 10-Q · filed 2019-08-19 |